Breaking stories
Donate Subscribe

Gentler cure for hepatitis C?

Consumer Corner December 13, 2013 NPR 0

The FDA is expected to approve a hepatitis C drug that avoids the need for interferon.

The FDA is expected to approve a hepatitis C drug that avoids the need for interferon.


Sign up for our free email alerts and follow us on Facebook and on Twitter @gahealthnews.
Help us fulfill our nonprofit mission with a tax-deductible donation!
About author

NPR

Add a comment

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *

Please leave these two fields as-is:

Foundation Support for GHN:
Georgia Health Foundation
Ford Foundation
Healthcare Georgia Foundation
Fund for Investigative Journalism
Kaiser Permanente
Thanks Mom & Dad Fund

Help us pursue our nonprofit mission with a tax-deductible donation.

Credit Cards

EVERY LITTLE BIT HELPS
Donations Welcome

Donate Icon

Copyright 2019 Georgia Health News a non-profit, 501 (c)3 organization.